Human immunodeficiency virus type 1 messenger RNA (HIV-1 mRNA)

Human immunodeficiency virus type 1 messenger RNA (HIV-1 mRNA) refers to the heterogeneous population of viral RNA transcripts produced in cells infected with HIV-1. These RNAs are central to the HIV-1 life cycle: they serve as the viral genome packaged into new virions, as templates for translation of viral polyproteins (Gag, Gag-Pol, Env), and as substrates for the synthesis of regulatory and accessory proteins[2][3][4][10]. HIV-1 mRNA includes unspliced, partially spliced, and fully spliced forms, encoding all viral proteins required for replication. Key structural elements within these RNAs, such as the trans-activation response element (TAR) and the ribosomal frameshift element, tightly regulate viral gene expression and are essential for viral replication and immune evasion[1][3][4][7]. While HIV-1 mRNA is critical for infection, it is not a canonical therapeutic target (such as a receptor, enzyme, or transporter). However, the RNA is a focus for some investigational therapies, including antisense oligonucleotides that aim to disrupt its function or translation[4].\nNote: "HIV-1 mRNA" is not a standardized therapeutic target name but rather describes a class of essential viral transcripts; therefore, it is not considered a drug target in the conventional sense.

Other names

HIV-1 RNAHIV-1 genomic RNAHIV-1 messenger RNAHIV-1 viral RNAHIV-1 transcript

Antisense oligonucleotides can bind HIV-1 mRNA to inhibit translation or modulate RNA structure[4]